India, May 13 -- Intelligent Bio Solutions Inc. (INBS) reported strong fiscal third-quarter results, highlighted by a 46% year-over-year increase in revenue and continued expansion of its recurring cartridge-based business model. The company said the performance reflects sustained commercial momentum ahead of key FDA regulatory milestones.
For the three months ended March 31, 2026, INBS generated $1.06 million in revenue, up from $728,867 in the same quarter last year, marking a 46% increase.
Cartridge sales5 rose 59% year-over-year to $703,538 and accounted for 66% of quarterly revenue, underscoring the strength of the company's razor-razorblade model.
Gross profit margin improved to 50.5%, compared with 46.8% in the prior-year quarter,...